A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies (Q50659071)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 February 2008

Language	Label	Description	Also known as
English	A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies	scientific article published on 12 February 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

1 reference

based on heuristic

inferred from title

author name string

Roland Beliard

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Tony Waegemans

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Dominique Notelet

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Léna Massad

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Frédéric Dhainaut

5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Christophe de Romeuf

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Eric Guemas

7

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Wouter Haazen

8

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Dominique Bourel

9

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Jean-Luc Teillaud

10

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Jean-François Prost

11

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

language of work or name

0 references

publication date

12 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

141

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

109-119

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Production of human monoclonal IgG antibodies against Rhesus (D) antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Production of human monoclonal antibody to rhesus D antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Rapid single-step FCGR3A genotyping based on SYBR Green I fluorescence in real-time multiplex allele-specific PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Monoclonal anti-D development programme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Engineered antibody Fc variants with enhanced effector function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.06985.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2008.06985.X

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18279459

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50659071&oldid=2256172143"